{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:27:43Z","timestamp":1787167663245,"version":"build-2736575974"},"reference-count":18,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T00:00:00Z","timestamp":1714348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacy Practice"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:p>Background: Opioid overdoses decrease when communities have access to naloxone. Clinicians play a key role in offering naloxone to high-risk chronic opioid patients. Managed care pharmacists within our health plan noted disproportionate processing for claims of opioid utilizers compared to claims of naloxone prescriptions. Objective: To increase naloxone access and prescribing to members who classify at a dosage with a higher risk for opioid overdose, defined as over 90 morphine milligram equivalents (MME). Methods: Multiple system-wide initiatives were implemented to improve naloxone access. A claims file was pulled monthly to identify members on opioids meeting MME criteria &gt;90 MME per day excluding members with cancer, sickle cell disease, or on hospice. A separate report was then matched to naloxone claims and prescribing percentages calculated. Results: 12\u2009444 utilizing members on opioids were identified from June 2019 prescription claims data. Of these, 131 were on opioids exceeding 90 MME per day, or 1.05% of utilizers, and the percentage of members exceeding 90 MME per day prescribed naloxone was 6.87%. By May 2023, the percentage of opioid utilizers exceeding 90 MME per day decreased to 0.58%. Naloxone prescribing increased to 41.18%. Conclusion: A multi-pronged approach to improve access to naloxone and continued educational efforts by our health plan increased naloxone prescribing in members on opioids exceeding 90 MME per day.<\/jats:p>","DOI":"10.1177\/08971900241247598","type":"journal-article","created":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T02:17:31Z","timestamp":1714443451000},"page":"1291-1296","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Increasing Naloxone Access and Prescribing for Patients on High-Dose Opioids From a Managed Care Pharmacy Health Plan Perspective"],"prefix":"10.1177","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-9345-4736","authenticated-orcid":false,"given":"Jodi P.","family":"Hansgen","sequence":"first","affiliation":[{"name":"Pharmacy Services, Baylor Scott & White Health Plan, Temple, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9807-5698","authenticated-orcid":false,"given":"Megan L.","family":"Robertson","sequence":"additional","affiliation":[{"name":"Pharmacy Services, Baylor Scott & White Health Plan, Temple, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9647-384X","authenticated-orcid":false,"given":"Ellen M.","family":"Verzino","sequence":"additional","affiliation":[{"name":"Pharmacy Services, Baylor Scott & White Health Plan, Temple, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4817-104X","authenticated-orcid":false,"given":"Lindsay M.","family":"Manning","sequence":"additional","affiliation":[{"name":"Pharmacy Services, Baylor Scott & White Health Plan, Temple, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,4,29]]},"reference":[{"key":"bibr1-08971900241247598","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02252-2"},{"key":"bibr2-08971900241247598","unstructured":"National Institute on Drug Abuse; National Institutes of Health; U.S. Department of Health and Human Services. Overdose death rates. https:\/\/nida.nih.gov\/research-topics\/trends-statistics\/overdose-death-rates. Accessed September 14, 2022."},{"key":"bibr3-08971900241247598","doi-asserted-by":"publisher","DOI":"10.15620\/cdc:122556"},{"key":"bibr4-08971900241247598","unstructured":"U.S. Department of Health and Human Services. Office of the surgeon general. U.S. Surgeon General\u2019s Advisory on Naloxone and Opioid Overdose. https:\/\/www.hhs.gov\/surgeongeneral\/reports-and-publications\/addiction-and-substance-misuse\/advisory-on-naloxone\/index.html. Accessed October 10, 2022."},{"key":"bibr5-08971900241247598","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f174"},{"key":"bibr6-08971900241247598","doi-asserted-by":"publisher","DOI":"10.1111\/add.13265"},{"key":"bibr7-08971900241247598","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000034"},{"key":"bibr8-08971900241247598","doi-asserted-by":"publisher","DOI":"10.1186\/s40621-015-0041-8"},{"key":"bibr9-08971900241247598","doi-asserted-by":"publisher","DOI":"10.1111\/add.13326"},{"key":"bibr10-08971900241247598","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr7103a1"},{"key":"bibr11-08971900241247598","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.45691"},{"key":"bibr12-08971900241247598","author":"CDC Vital Signs","year":"2019","journal-title":"MMWR (Morb Mortal Wkly Rep)"},{"key":"bibr13-08971900241247598","unstructured":"National Institute on Drug Abuse; National Institutes of Health; U.S. Department of Health and Human Services. Naloxone drug facts. https:\/\/nida.nih.gov\/publications\/drugfacts\/naloxone. Accessed August 12, 2022."},{"key":"bibr14-08971900241247598","unstructured":"The Pew Charitable Trusts. Expanded access to naloxone can curb opioid overdose deaths. Issue Brief. Projects: Substance Use Prevention and Treatment; 2020. https:\/\/www.pewtrusts.org\/en\/research-and-analysis\/issue-briefs\/2020\/10\/expanded-access-to-naloxone-can-curb-opioid-overdose-deaths. Accessed October 10, 2022."},{"key":"bibr15-08971900241247598","unstructured":"Seiler N, Horton KB, Malcarney M. Medicaid reimbursement for naloxone: a toolkit for advocates. 2014. https:\/\/hsrc.himmelfarb.gwu.edu\/sphhs_policy_facpubs\/858. Accessed September 14, 2022."},{"key":"bibr16-08971900241247598","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2016.12.076"},{"key":"bibr17-08971900241247598","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6501e1"},{"key":"bibr18-08971900241247598","unstructured":"Naloxone. The opioid reversal drug that saves lives. Health and Human Services. https:\/\/www.hhs.gov\/opioids\/sites\/default\/files\/2018-12\/naloxone-coprescribing-guidance.pdf. Accessed October 30, 2022."}],"container-title":["Journal of Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/08971900241247598","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/08971900241247598","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/08971900241247598","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:38:26Z","timestamp":1777509506000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/08971900241247598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,29]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10.1177\/08971900241247598"],"URL":"https:\/\/doi.org\/10.1177\/08971900241247598","relation":{},"ISSN":["0897-1900","1531-1937"],"issn-type":[{"value":"0897-1900","type":"print"},{"value":"1531-1937","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,29]]}}}